EX-99.8 21 ea020512201ex99-8_arcabio.htm CONSENT OF CARL DAMBKOWSKI TO SERVE AS A DIRECTOR OF ARCA BIOPHARMA, INC., TO BE RENAMED ORUKA THERAPEUTICS, INC

Exhibit 99.8

 

Consent to be Named as a Director

 

ARCA biopharma, Inc. is filing a Registration Statement on Form S-4 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). In connection therewith, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named in the Registration Statement and any and all amendments and supplements thereto as a future member of the board of directors of the combined company following the consummation of the merger. I also consent to the filing of this consent as an exhibit to the Registration Statement and any amendments thereto.

 

Sincerely,

 

/s/ Carl Dambkowski

 
Name:  Carl Dambkowski